# A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease

> **NCT02637141** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 64 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **BIOLOGICAL:** AMG 714
- **BIOLOGICAL:** Placebo
- **OTHER:** Placebo Gluten Challenge
- **OTHER:** Gluten Challenge

## Key facts

- **NCT ID:** NCT02637141
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-13
- **Primary completion:** 2017-02-15
- **Final completion:** 2017-03-14
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02637141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02637141, "A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02637141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*